Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

ABT-089 candidate drug for Alzheimer's disease

April 12, 1996

Carbonic anhydrase inhibitor tested for parkinsonism

April 12, 1996

Conjugated estrogens + pravastatin effective in treating hypercholesterolemia in women

April 12, 1996

New alpha2-adrenoceptor agonist reported by Allergan

April 12, 1996

NT-3 lessens cisplatin toxicity in rats

April 12, 1996

S-28679, a new interferon biosynthesis inducer from 3M

April 12, 1996

L-742728 selected by Merck & Co. for further evaluation

April 12, 1996

HGH delivery agents reported by Emisphere Technologies

April 5, 1996

Provir to enter phase II soon

April 5, 1996

SB-214857 in preclinical studies

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...